California Technology Ventures LLC
11/29/2014 | Press release | Archived content
California Technology Ventures Gets Exit from AngioScore
Pasadena-based venture capital firm California Technology Ventures has scored an exit at one of its portfolio firms, selling cardiac catheter maker AngioScore, to medical device firm Spectranetics. Spectranetics said it would pay $230M plus earnout for AngioScore, which was backed by California Technology Ventures, Innomed Ventures, Linkagene LP, Pelion Ventures, Psilos Group Management, QuestMark Partners, Saints Capital and Telegraph Hill Partners. California Technology Ventures has been an investor in AngioScore since at least 2004, as part of the company's Series B funding.
California Technology Ventures LLC published this content on November 29, 2014, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 06, 2026 at 06:01 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]